SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Microcap & Penny Stocks : BPRX Turn around

 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: Instock who wrote ()3/14/1997 9:37:00 AM
From: Marc D.   of 197
 
Bradley Pharmaceuticals 4Q Net 4c A Share Vs Loss 38c >BPRX

Dow Jones News Service ~ March 14, 1997 ~ 8:25 am EST
Bradley Pharmaceuticals Inc. - Fairchild, N.J.
4th Quar Dec. 31:
1996 1995
Sales $3,716,326 $2,615,679
Net income 272,679 (2,806,451)
Avg shrs 7,200,000 7,500,000
Shr earns
Net income .04 (.38)
Year:
Sales 12,769,266 10,621,061
Net income 1,598,507 (6,921,241)
Avg shrs 7,200,000 7,350,000
Shr earns
Net income .22 (.94)

Figures in parentheses are losses.

Bradley Pharmaceuticals Inc. (BPRX) said its 1996 results included costs of $1.6 million for a one-time legal settlement. The company's 1995 results included a $1.3 million charge for a change in trade price discounting and a $1 million adjustment, recorded in the fourth quarter, for reserves and allowances principally relating to trade price discounts, inventory and promotional materials.

Bradley Pharmacueticals makes and markets brandname prescription and
over-the-counter pharmaceutical and health-related products.

(END) DOW JONES NEWS 03-14-97

8:25 AM
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext